share_log

HC Wainwright & Co. Maintains Buy on EyePoint Pharmaceuticals, Maintains $33 Price Target

HC Wainwright & Co. Maintains Buy on EyePoint Pharmaceuticals, Maintains $33 Price Target

HC Wainwright & Co.維持對EyePoint製藥的買入,維持33美元的目標股價
Benzinga ·  03/08 13:06

HC Wainwright & Co. analyst Yi Chen maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and maintains $33 price target.

HC Wainwright & Co. 分析師陳毅維持EyePoint Pharmicals(納斯達克股票代碼:EYPT)的買入並維持33美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論